Surgery Partners, Inc. (NASDAQ: SGRY) reported Q1 EPS of ($0.06), $0.13 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $286.2 million versus the consensus estimate of $292.56 million.

Full Year 2017 Guidance

For 2017, the Company reiterates the guidance provided on our conference call in March of this year. The Company continues to expect revenue growth of 9% to 11% and Adjusted EBITDA growth in the range of 10% to 15% over 2016.

For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.